Pfizer Inc. (NYSE:PFE) to Post Q1 2023 Earnings of $0.72 Per Share, Jefferies Financial Group Forecasts

Jefferies Financial Group lowered their Q1 2023 earnings estimates for shares of Pfizer in a note issued to investors on Friday, March 17th. Jefferies Financial Group analyst A. Tewari now anticipates that the biopharmaceutical company will post earnings per share of $0.72 for the quarter, down from their previous estimate of $0.78. Jefferies Financial Group has a “Hold” rating and a $43.00 price objective on the stock.

Pfizer Inc. (NYSE:PFE) to Post Q1 2023 Earnings of $0.72 Per Share, Jefferies Financial Group Forecasts Read Post »

Deutsche Bank Maintains Micron Technology (Nasdaq:MU) “Hold” rating with a $55 price target

Deutsche Bank continues to see the dynamic decline in prices for DRAM and NAND chips as the biggest variable in Micron Technology’s (Nasdaq:MU) 2023 results. Deutsche Bank now expects challenges in the company’s fiscal second and third quarters, saying inventory adjustments for enterprise and cloud customers are well underway, while the latest industry survey shows that selling price erosion “remains severe.” In addition, the analyst told investors in a research note that unit sales data from peers suggest that Micron’s underlying assumption for a mid-term demand recovery in 2023 “may be overly optimistic.” Deutsche Bank sees Micron Technology’s current share price level as risk-reward balanced and maintains a “hold” rating with a target price of $55.

Deutsche Bank Maintains Micron Technology (Nasdaq:MU) “Hold” rating with a $55 price target Read Post »

TD Cowen Raised its UiPath (NYSE:PATH) price target to $20 to maintain its outperform rating

TD Cowen analyst Bryan Bergin will raise his price target on UiPath (NYSE:PATH) to $20 from $18 and maintain an outperform rating on the stock. The analyst said that adjusted operating profit exceeded expectations by 60 as the company performed a solid fourth quarter and financial guidance for 2024 provided a good annual recurring revenue (ARR) and revenue threshold, which was 3/4 above consensus expectations.

TD Cowen Raised its UiPath (NYSE:PATH) price target to $20 to maintain its outperform rating Read Post »

Wells Fargo raised its price target on Meta Platforms (NASDAQ:META) to $280 to maintain its overweight rating

Wells Fargo raised its price target on Meta Platforms (NASDAQ:META) to $280 from $250 and maintained its overweight rating on the stock. The bank noted that Meta has strengthened its commitment to improving organizational efficiency, announcing the layoff of about 10,000 employees during 2023 and lowering its operating expenditure guidance for 2023 to $86 billion to $92 billion from the previous $89 billion to $95 billion.

Wells Fargo raised its price target on Meta Platforms (NASDAQ:META) to $280 to maintain its overweight rating Read Post »

Mizuho raised UiPath (NYSE:PATH) price target to $16 and maintain its neutral rating

Mizuho analyst Siti Panigrahi will raise its price target on UiPath (NYSE:PATH) to $16 from $15 and maintain a neutral rating on the stock. The analyst told investors in a research note that the company had strong fourth-quarter results and provided fiscal 2024 growth guidance in line with investors’ daily outlook. The bank is encouraged by the latest results and UiPath’s continued repositioning of the market to businesses.

Mizuho raised UiPath (NYSE:PATH) price target to $16 and maintain its neutral rating Read Post »

DA Davidson maintains Adobe’s (NASDAQ:ADBE) neutral rating and $350 price target

DA Davidson analyst Gil Luria maintains a neutral rating on Adobe (NASDAQ:ADBE) and a $350 price target. The analyst told investors in a research note that the company is ready for slower growth in the software market in 2023 and that the acquisition of Figma represents a good strategic fit; Despite the limited upside in the guidance, there is some ongoing uncertainty surrounding the Figma trade.

DA Davidson maintains Adobe’s (NASDAQ:ADBE) neutral rating and $350 price target Read Post »

Scroll to Top